SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-022255
Filing Date
2023-06-23
Accepted
2023-06-23 16:25:10
Documents
13
Period of Report
2023-06-21
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 55546
  Complete submission text file 0001493152-23-022255.txt   284691

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE hrow-20230621.xsd EX-101.SCH 4212
3 XBRL DEFINITION FILE hrow-20230621_def.xml EX-101.DEF 27404
4 XBRL LABEL FILE hrow-20230621_lab.xml EX-101.LAB 37859
5 XBRL PRESENTATION FILE hrow-20230621_pre.xml EX-101.PRE 26021
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6235
Mailing Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215
Business Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215 615.733.4731
HARROW HEALTH, INC. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35814 | Film No.: 231038045
SIC: 2834 Pharmaceutical Preparations